CG Oncology (CGON) Amortizatization of Intangibles (2023 - 2025)

CG Oncology has reported Amortizatization of Intangibles for 3 years, with the latest figure at -$951000.0 in Q4 2025.

• For the quarter ending Q4 2025, Amortizatization of Intangibles rose 24.22% year-over-year to -$951000.0; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 79.69% YoY), and the FY2025 full-year result was $1.0 million, down 79.69% from the prior year.
• Amortizatization of Intangibles for Q4 2025 stood at -$951000.0, down from -$201000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $2.5 million in Q2 2024, with the low at -$1.3 million in Q4 2024.
• Historically, Amortizatization of Intangibles has averaged $862400.0 across 3 years, with a median of $1.3 million in 2023.
• The largest YoY upside for Amortizatization of Intangibles was 37.33% in 2024 against a maximum downside of 185.61% in 2024.
• CG Oncology's Amortizatization of Intangibles stood at $1.5 million in 2023, then sank by 185.61% to -$1.3 million in 2024, then climbed by 24.22% to -$951000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at -$951000.0 (Q4 2025), -$201000.0 (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.